| 0 |
GAMING DISORDER |
3 |
0.1579 |
| 1 |
CREATINE KINASE ABNORMAL |
3 |
0.1250 |
| 2 |
STEROID DEPENDENCE |
106 |
0.1207 |
| 3 |
ANTI-TRANSGLUTAMINASE ANTIBODY INCREASED |
7 |
0.1207 |
| 4 |
CATARRH |
106 |
0.1173 |
| 5 |
ORTHODONTIC PROCEDURE |
6 |
0.1111 |
| 6 |
DECREASED EYE CONTACT |
30 |
0.0987 |
| 7 |
ADRENERGIC SYNDROME |
7 |
0.0864 |
| 8 |
OPPOSITIONAL DEFIANT DISORDER |
33 |
0.0835 |
| 9 |
PREMENSTRUAL DYSPHORIC DISORDER |
14 |
0.0690 |
| 10 |
SEXUAL INHIBITION |
6 |
0.0645 |
| 11 |
BURNS SECOND DEGREE |
107 |
0.0609 |
| 12 |
RABBIT SYNDROME |
9 |
0.0542 |
| 13 |
CHOREOATHETOSIS |
36 |
0.0530 |
| 14 |
INTENTIONAL SELF-INJURY |
1047 |
0.0518 |
| 15 |
SELECTIVE MUTISM |
4 |
0.0476 |
| 16 |
DRUG METABOLITE LEVEL HIGH |
4 |
0.0476 |
| 17 |
ADULTERATED PRODUCT |
9 |
0.0450 |
| 18 |
EXECUTIVE DYSFUNCTION |
24 |
0.0443 |
| 19 |
SYMPATHOMIMETIC EFFECT |
10 |
0.0433 |
| 20 |
SACCADIC EYE MOVEMENT |
7 |
0.0419 |
| 21 |
DISRUPTIVE MOOD DYSREGULATION DISORDER |
3 |
0.0405 |
| 22 |
INABILITY TO AFFORD MEDICATION |
400 |
0.0402 |
| 23 |
FOETAL ALCOHOL SYNDROME |
4 |
0.0400 |
| 24 |
CHANGE IN SUSTAINED ATTENTION |
12 |
0.0399 |
| 25 |
WHITE BLOOD CELLS URINE |
11 |
0.0396 |
| 26 |
DYSANIA |
3 |
0.0390 |
| 27 |
PICA |
7 |
0.0389 |
| 28 |
ALCOHOL POISONING |
100 |
0.0373 |
| 29 |
ORGANIC BRAIN SYNDROME |
7 |
0.0372 |
| 30 |
SENSORY OVERLOAD |
7 |
0.0355 |
| 31 |
SUBCHORIONIC HAEMATOMA |
6 |
0.0341 |
| 32 |
DELUSION OF PARASITOSIS |
5 |
0.0318 |
| 33 |
HYPOPNOEA |
106 |
0.0305 |
| 34 |
POLYDIPSIA PSYCHOGENIC |
6 |
0.0293 |
| 35 |
ACUTE MACULAR NEURORETINOPATHY |
5 |
0.0292 |
| 36 |
ACCELERATED IDIOVENTRICULAR RHYTHM |
4 |
0.0270 |
| 37 |
VEIN DISCOLOURATION |
12 |
0.0255 |
| 38 |
THERAPEUTIC RESPONSE CHANGED |
152 |
0.0240 |
| 39 |
OPSOCLONUS MYOCLONUS |
5 |
0.0235 |
| 40 |
PNEUMOPERICARDIUM |
4 |
0.0233 |
| 41 |
BINGE EATING |
24 |
0.0222 |
| 42 |
PRODUCT AVAILABILITY ISSUE |
506 |
0.0222 |
| 43 |
AMNIORRHOEA |
4 |
0.0211 |
| 44 |
SUICIDE THREAT |
8 |
0.0205 |
| 45 |
ELECTROCARDIOGRAM CHANGE |
19 |
0.0200 |
| 46 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
75 |
0.0193 |
| 47 |
VENTRICULAR DYSKINESIA |
4 |
0.0192 |
| 48 |
AUTISM SPECTRUM DISORDER |
103 |
0.0187 |
| 49 |
ANISOCORIA |
7 |
0.0185 |
| 50 |
SOCIAL ANXIETY DISORDER |
12 |
0.0183 |
| 51 |
INSURANCE ISSUE |
269 |
0.0176 |
| 52 |
INTENTIONAL OVERDOSE |
1099 |
0.0171 |
| 53 |
COMPULSIONS |
11 |
0.0165 |
| 54 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
69 |
0.0164 |
| 55 |
SELF-DESTRUCTIVE BEHAVIOUR |
14 |
0.0161 |
| 56 |
SUSPECTED PRODUCT TAMPERING |
9 |
0.0160 |
| 57 |
BODY DYSMORPHIC DISORDER |
6 |
0.0160 |
| 58 |
BRONCHIECTASIS |
106 |
0.0157 |
| 59 |
TRICHOTILLOMANIA |
9 |
0.0154 |
| 60 |
DERMATILLOMANIA |
9 |
0.0151 |
| 61 |
HYPERTENSIVE URGENCY |
8 |
0.0144 |
| 62 |
PAROSMIA |
109 |
0.0144 |
| 63 |
TIME PERCEPTION ALTERED |
5 |
0.0138 |
| 64 |
RHINITIS |
109 |
0.0135 |
| 65 |
GINGIVAL PAIN |
107 |
0.0134 |
| 66 |
DEFIANT BEHAVIOUR |
4 |
0.0130 |
| 67 |
DRUG TOLERANCE INCREASED |
10 |
0.0128 |
| 68 |
CARDIAC MURMUR |
107 |
0.0124 |
| 69 |
JOB DISSATISFACTION |
8 |
0.0123 |
| 70 |
MEAN PLATELET VOLUME DECREASED |
10 |
0.0119 |
| 71 |
HYPERTENSIVE EMERGENCY |
14 |
0.0119 |
| 72 |
HYPONATRAEMIC SEIZURE |
3 |
0.0118 |
| 73 |
BOREDOM |
4 |
0.0118 |
| 74 |
PRODUCT MONITORING ERROR |
17 |
0.0118 |
| 75 |
RECALLED PRODUCT ADMINISTERED |
111 |
0.0116 |
| 76 |
ABDOMINAL LYMPHADENOPATHY |
10 |
0.0115 |
| 77 |
NEURODEGENERATIVE DISORDER |
7 |
0.0113 |
| 78 |
DRUG-GENETIC INTERACTION |
4 |
0.0112 |
| 79 |
ANION GAP |
7 |
0.0110 |
| 80 |
INTRUSIVE THOUGHTS |
13 |
0.0110 |
| 81 |
THYROXINE FREE DECREASED |
6 |
0.0106 |
| 82 |
THEFT |
7 |
0.0105 |
| 83 |
AVERSION |
3 |
0.0104 |
| 84 |
BLUE TOE SYNDROME |
4 |
0.0102 |
| 85 |
ALCOHOL INTOLERANCE |
7 |
0.0099 |
| 86 |
DISSOCIATIVE DISORDER |
7 |
0.0097 |
| 87 |
BRUXISM |
52 |
0.0096 |
| 88 |
EOSINOPHILIC PNEUMONIA ACUTE |
8 |
0.0092 |
| 89 |
SENSITISATION |
7 |
0.0092 |
| 90 |
MITE ALLERGY |
6 |
0.0092 |
| 91 |
IMPULSIVE BEHAVIOUR |
34 |
0.0091 |
| 92 |
DRUG EFFECT FASTER THAN EXPECTED |
3 |
0.0090 |
| 93 |
PERINATAL DEPRESSION |
4 |
0.0089 |
| 94 |
GROWTH FAILURE |
3 |
0.0087 |
| 95 |
BASAL GANGLIA HAEMORRHAGE |
7 |
0.0086 |
| 96 |
INTELLECTUAL DISABILITY |
13 |
0.0086 |
| 97 |
PRODUCT SUBSTITUTION ISSUE |
482 |
0.0084 |
| 98 |
BACTERIAL DISEASE CARRIER |
6 |
0.0082 |
| 99 |
MONOCYTE COUNT DECREASED |
10 |
0.0082 |
| 100 |
HYPERKINESIA |
17 |
0.0080 |
| 101 |
WATER INTOXICATION |
4 |
0.0079 |
| 102 |
HOMICIDAL IDEATION |
32 |
0.0079 |
| 103 |
MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED |
13 |
0.0078 |
| 104 |
IMPAIRED QUALITY OF LIFE |
112 |
0.0078 |
| 105 |
EMOTIONAL POVERTY |
13 |
0.0074 |
| 106 |
BRAIN FOG |
115 |
0.0073 |
| 107 |
DRUG EFFECT LESS THAN EXPECTED |
107 |
0.0072 |
| 108 |
TRISMUS |
37 |
0.0072 |
| 109 |
TIC |
39 |
0.0071 |
| 110 |
PRODUCT PHYSICAL ISSUE |
143 |
0.0071 |
| 111 |
DISORGANISED SPEECH |
13 |
0.0070 |
| 112 |
BURNOUT SYNDROME |
4 |
0.0070 |
| 113 |
NARCOLEPSY |
13 |
0.0069 |
| 114 |
BODY MASS INDEX DECREASED |
3 |
0.0065 |
| 115 |
IMPAIRED WORK ABILITY |
138 |
0.0064 |
| 116 |
STRESS CARDIOMYOPATHY |
37 |
0.0064 |
| 117 |
FOREIGN BODY IN EYE |
6 |
0.0063 |
| 118 |
CHRONIC HEPATITIS |
5 |
0.0062 |
| 119 |
TUBULOINTERSTITIAL NEPHRITIS |
114 |
0.0061 |
| 120 |
DISTRACTIBILITY |
7 |
0.0061 |
| 121 |
SPUTUM ABNORMAL |
4 |
0.0060 |
| 122 |
FOOD INTERACTION |
10 |
0.0057 |
| 123 |
OCULOGYRIC CRISIS |
12 |
0.0056 |
| 124 |
LANGUAGE DISORDER |
12 |
0.0055 |
| 125 |
SUSPECTED PRODUCT QUALITY ISSUE |
10 |
0.0055 |
| 126 |
AMPHETAMINES POSITIVE |
4 |
0.0053 |
| 127 |
ENCEPHALITIS AUTOIMMUNE |
7 |
0.0053 |
| 128 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
7 |
0.0052 |
| 129 |
HYPERVIGILANCE |
5 |
0.0052 |
| 130 |
NEAR DEATH EXPERIENCE |
17 |
0.0051 |
| 131 |
DRUG TOLERANCE |
26 |
0.0051 |
| 132 |
SUSPECTED SUICIDE |
24 |
0.0051 |
| 133 |
CULTURE URINE POSITIVE |
7 |
0.0050 |
| 134 |
HEAT EXHAUSTION |
4 |
0.0050 |
| 135 |
FEELING OF DESPAIR |
23 |
0.0049 |
| 136 |
KNEE DEFORMITY |
7 |
0.0047 |
| 137 |
ACTIVITIES OF DAILY LIVING DECREASED |
3 |
0.0047 |
| 138 |
SEROTONIN SYNDROME |
90 |
0.0047 |
| 139 |
MENTAL FATIGUE |
7 |
0.0047 |
| 140 |
ELECTRIC SHOCK SENSATION |
13 |
0.0046 |
| 141 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
222 |
0.0046 |
| 142 |
DISTURBANCE IN ATTENTION |
249 |
0.0046 |
| 143 |
HEAT STROKE |
7 |
0.0046 |
| 144 |
AFFECT LABILITY |
44 |
0.0046 |
| 145 |
CARDIAC OUTPUT DECREASED |
4 |
0.0045 |
| 146 |
VULVOVAGINAL CANDIDIASIS |
6 |
0.0044 |
| 147 |
STRESS AT WORK |
5 |
0.0044 |
| 148 |
PNEUMOMEDIASTINUM |
8 |
0.0044 |
| 149 |
METABOLIC SURGERY |
5 |
0.0044 |
| 150 |
FEELING OF RELAXATION |
3 |
0.0044 |
| 151 |
HYPERSEXUALITY |
8 |
0.0044 |
| 152 |
IMPULSE-CONTROL DISORDER |
9 |
0.0044 |
| 153 |
BEZOAR |
6 |
0.0043 |
| 154 |
DISTURBANCE IN SEXUAL AROUSAL |
4 |
0.0043 |
| 155 |
HAND DERMATITIS |
3 |
0.0043 |
| 156 |
FREQUENT BOWEL MOVEMENTS |
117 |
0.0043 |
| 157 |
STREPTOCOCCAL INFECTION |
24 |
0.0043 |
| 158 |
HYPERPHAGIA |
17 |
0.0043 |
| 159 |
EDUCATIONAL PROBLEM |
7 |
0.0042 |
| 160 |
HAEMORRHAGE IN PREGNANCY |
6 |
0.0042 |
| 161 |
IRRITABILITY |
250 |
0.0042 |
| 162 |
PATIENT DISSATISFACTION WITH TREATMENT |
8 |
0.0041 |
| 163 |
BLOOD IMMUNOGLOBULIN G INCREASED |
5 |
0.0041 |
| 164 |
TOBACCO USER |
6 |
0.0040 |
| 165 |
INDIFFERENCE |
3 |
0.0040 |
| 166 |
APATHY |
58 |
0.0040 |
| 167 |
BASOPHIL COUNT INCREASED |
3 |
0.0040 |
| 168 |
DILATED CARDIOMYOPATHY |
4 |
0.0040 |
| 169 |
ABORTION MISSED |
5 |
0.0039 |
| 170 |
DISSOCIATION |
30 |
0.0039 |
| 171 |
FLAT AFFECT |
9 |
0.0039 |
| 172 |
SWOLLEN TONGUE |
121 |
0.0039 |
| 173 |
TUNNEL VISION |
7 |
0.0037 |
| 174 |
PSYCHOMOTOR HYPERACTIVITY |
62 |
0.0037 |
| 175 |
LOGORRHOEA |
13 |
0.0037 |
| 176 |
TROPONIN I INCREASED |
6 |
0.0036 |
| 177 |
FACIAL SPASM |
4 |
0.0036 |
| 178 |
MAST CELL ACTIVATION SYNDROME |
5 |
0.0036 |
| 179 |
STATUS EPILEPTICUS |
40 |
0.0035 |
| 180 |
BEHAVIOUR DISORDER |
19 |
0.0035 |
| 181 |
CARDIOGENIC SHOCK |
50 |
0.0035 |
| 182 |
SERUM FERRITIN DECREASED |
6 |
0.0035 |
| 183 |
TACHYPHRENIA |
12 |
0.0035 |
| 184 |
PSYCHOTIC SYMPTOM |
7 |
0.0034 |
| 185 |
OBSESSIVE THOUGHTS |
6 |
0.0033 |
| 186 |
SLEEP DEFICIT |
7 |
0.0033 |
| 187 |
BIPOLAR DISORDER |
36 |
0.0033 |
| 188 |
COORDINATION ABNORMAL |
46 |
0.0033 |
| 189 |
NIGHTMARE |
114 |
0.0033 |
| 190 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
15 |
0.0033 |
| 191 |
MYDRIASIS |
42 |
0.0033 |
| 192 |
PREMATURE SEPARATION OF PLACENTA |
5 |
0.0032 |
| 193 |
SUICIDAL IDEATION |
296 |
0.0032 |
| 194 |
HYPERACUSIS |
12 |
0.0032 |
| 195 |
SUBSTANCE USE |
5 |
0.0032 |
| 196 |
PRODUCT FORMULATION ISSUE |
21 |
0.0032 |
| 197 |
BETA HAEMOLYTIC STREPTOCOCCAL INFECTION |
4 |
0.0032 |
| 198 |
SUBSTANCE-INDUCED PSYCHOTIC DISORDER |
7 |
0.0031 |
| 199 |
RED CELL DISTRIBUTION WIDTH INCREASED |
13 |
0.0031 |
| 200 |
CORNEAL OEDEMA |
7 |
0.0031 |
| 201 |
DEPRESSIVE SYMPTOM |
11 |
0.0031 |
| 202 |
OBSESSIVE-COMPULSIVE DISORDER |
25 |
0.0031 |
| 203 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
110 |
0.0031 |
| 204 |
HALLUCINATIONS, MIXED |
13 |
0.0031 |
| 205 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
19 |
0.0031 |
| 206 |
COUNTERFEIT PRODUCT ADMINISTERED |
4 |
0.0031 |
| 207 |
SEXUAL DYSFUNCTION |
36 |
0.0031 |
| 208 |
ACCIDENTAL OVERDOSE |
112 |
0.0031 |
| 209 |
POISONING DELIBERATE |
29 |
0.0031 |
| 210 |
SUSPECTED COUNTERFEIT PRODUCT |
12 |
0.0030 |
| 211 |
ANTISOCIAL BEHAVIOUR |
3 |
0.0030 |
| 212 |
FRUSTRATION TOLERANCE DECREASED |
24 |
0.0030 |
| 213 |
TORSADE DE POINTES |
23 |
0.0029 |
| 214 |
CLONUS |
8 |
0.0029 |
| 215 |
PREMENSTRUAL SYNDROME |
4 |
0.0029 |
| 216 |
PULSE ABNORMAL |
7 |
0.0029 |
| 217 |
SUICIDAL BEHAVIOUR |
12 |
0.0029 |
| 218 |
CARDIAC FAILURE ACUTE |
19 |
0.0028 |
| 219 |
MEDICATION ERROR |
158 |
0.0028 |
| 220 |
EUPHORIC MOOD |
29 |
0.0028 |
| 221 |
ACUTE PSYCHOSIS |
7 |
0.0028 |
| 222 |
TACHYARRHYTHMIA |
7 |
0.0028 |
| 223 |
PRODUCT TAMPERING |
5 |
0.0028 |
| 224 |
DEPRESSED MOOD |
147 |
0.0028 |
| 225 |
AGGRESSION |
139 |
0.0028 |
| 226 |
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY |
3 |
0.0028 |
| 227 |
BLADDER DILATATION |
3 |
0.0028 |
| 228 |
JUDGEMENT IMPAIRED |
4 |
0.0028 |
| 229 |
GENERALISED ANXIETY DISORDER |
4 |
0.0027 |
| 230 |
HYPOMANIA |
10 |
0.0027 |
| 231 |
RECTAL HAEMORRHAGE |
116 |
0.0027 |
| 232 |
TINNITUS |
123 |
0.0027 |
| 233 |
AFFECTIVE DISORDER |
21 |
0.0027 |
| 234 |
FEAR OF DEATH |
6 |
0.0027 |
| 235 |
LOSS OF EMPLOYMENT |
8 |
0.0026 |
| 236 |
SELF-INJURIOUS IDEATION |
11 |
0.0026 |
| 237 |
HYPERREFLEXIA |
9 |
0.0026 |
| 238 |
DISCOURAGEMENT |
6 |
0.0026 |
| 239 |
JAW DISORDER |
14 |
0.0026 |
| 240 |
COLITIS ULCERATIVE |
114 |
0.0025 |
| 241 |
REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME |
5 |
0.0025 |
| 242 |
MYOPIA |
6 |
0.0025 |
| 243 |
ANGER |
85 |
0.0025 |
| 244 |
ALLERGIC REACTION TO EXCIPIENT |
5 |
0.0025 |
| 245 |
BRONCHIAL HYPERREACTIVITY |
3 |
0.0025 |
| 246 |
MANIA |
41 |
0.0025 |
| 247 |
ECZEMA |
128 |
0.0024 |
| 248 |
METABOLIC SYNDROME |
4 |
0.0024 |
| 249 |
OVERWEIGHT |
13 |
0.0024 |
| 250 |
AKATHISIA |
33 |
0.0024 |
| 251 |
NEGATIVE THOUGHTS |
7 |
0.0024 |
| 252 |
PERSONALITY CHANGE |
22 |
0.0024 |
| 253 |
TORTICOLLIS |
5 |
0.0024 |
| 254 |
WITHDRAWAL SYNDROME |
99 |
0.0024 |
| 255 |
METABOLIC ENCEPHALOPATHY |
7 |
0.0023 |
| 256 |
TEARFULNESS |
10 |
0.0023 |
| 257 |
PRODUCT COUNTERFEIT |
4 |
0.0023 |
| 258 |
CRANIOCEREBRAL INJURY |
7 |
0.0023 |
| 259 |
PRODUCT ADMINISTRATION INTERRUPTED |
18 |
0.0023 |
| 260 |
DRUG SCREEN NEGATIVE |
4 |
0.0023 |
| 261 |
FEELING JITTERY |
43 |
0.0023 |
| 262 |
DRUG WITHDRAWAL CONVULSIONS |
4 |
0.0022 |
| 263 |
YAWNING |
6 |
0.0022 |
| 264 |
AGITATION |
165 |
0.0022 |
| 265 |
ANION GAP INCREASED |
3 |
0.0022 |
| 266 |
TEMPERATURE REGULATION DISORDER |
5 |
0.0022 |
| 267 |
ANORGASMIA |
6 |
0.0022 |
| 268 |
HAEMATOCHEZIA |
122 |
0.0022 |
| 269 |
THERAPEUTIC RESPONSE DECREASED |
134 |
0.0022 |
| 270 |
ACUTE HEPATIC FAILURE |
30 |
0.0022 |
| 271 |
AGORAPHOBIA |
3 |
0.0022 |
| 272 |
SINUS TACHYCARDIA |
31 |
0.0022 |
| 273 |
SOCIAL PROBLEM |
9 |
0.0022 |
| 274 |
HEART RATE ABNORMAL |
12 |
0.0021 |
| 275 |
CARDIAC DYSFUNCTION |
8 |
0.0021 |
| 276 |
CRYING |
78 |
0.0021 |
| 277 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
11 |
0.0021 |
| 278 |
PALPITATIONS |
249 |
0.0021 |
| 279 |
GLUTEN SENSITIVITY |
3 |
0.0021 |
| 280 |
HYPERCOAGULATION |
4 |
0.0021 |
| 281 |
MOOD ALTERED |
57 |
0.0021 |
| 282 |
POOR QUALITY PRODUCT ADMINISTERED |
22 |
0.0021 |
| 283 |
SOCIAL AVOIDANT BEHAVIOUR |
12 |
0.0021 |
| 284 |
SUICIDE ATTEMPT |
124 |
0.0020 |
| 285 |
VERTIGO |
124 |
0.0020 |
| 286 |
UNDERWEIGHT |
4 |
0.0020 |
| 287 |
DROOLING |
14 |
0.0020 |
| 288 |
POLYMENORRHOEA |
7 |
0.0020 |
| 289 |
THINKING ABNORMAL |
37 |
0.0020 |
| 290 |
VITAMIN B12 DEFICIENCY |
8 |
0.0020 |
| 291 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
3 |
0.0020 |
| 292 |
APPETITE DISORDER |
13 |
0.0020 |
| 293 |
POOR QUALITY SLEEP |
42 |
0.0019 |
| 294 |
REBOUND EFFECT |
22 |
0.0019 |
| 295 |
DAYDREAMING |
3 |
0.0019 |
| 296 |
PANIC REACTION |
14 |
0.0019 |
| 297 |
PERFORMANCE STATUS DECREASED |
9 |
0.0019 |
| 298 |
MONOCYTE COUNT INCREASED |
7 |
0.0019 |
| 299 |
INSULIN RESISTANCE |
4 |
0.0019 |
| 300 |
PARANOIA |
33 |
0.0019 |
| 301 |
INHIBITORY DRUG INTERACTION |
3 |
0.0019 |
| 302 |
INAPPROPRIATE AFFECT |
3 |
0.0019 |
| 303 |
DEREALISATION |
4 |
0.0019 |
| 304 |
VULVOVAGINAL DRYNESS |
6 |
0.0019 |
| 305 |
MIGRAINE |
176 |
0.0018 |
| 306 |
HUNGER |
25 |
0.0018 |
| 307 |
PSYCHOTIC DISORDER |
53 |
0.0018 |
| 308 |
ILEUS PARALYTIC |
8 |
0.0018 |
| 309 |
DRUG DIVERSION |
11 |
0.0018 |
| 310 |
DYSPHORIA |
9 |
0.0018 |
| 311 |
POLYDIPSIA |
7 |
0.0018 |
| 312 |
EROSIVE OESOPHAGITIS |
3 |
0.0018 |
| 313 |
FOOD AVERSION |
3 |
0.0018 |
| 314 |
ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE |
3 |
0.0018 |
| 315 |
NEUTROPHIL COUNT INCREASED |
18 |
0.0018 |
| 316 |
CEREBRAL ATROPHY |
7 |
0.0018 |
| 317 |
PRODUCT COLOUR ISSUE |
9 |
0.0018 |
| 318 |
HAIR GROWTH ABNORMAL |
12 |
0.0017 |
| 319 |
KIDNEY FIBROSIS |
3 |
0.0017 |
| 320 |
VOMITING PROJECTILE |
5 |
0.0017 |
| 321 |
DEEP VEIN THROMBOSIS |
111 |
0.0017 |
| 322 |
MUSCLE CONTRACTIONS INVOLUNTARY |
6 |
0.0017 |
| 323 |
RESTLESS LEGS SYNDROME |
31 |
0.0017 |
| 324 |
ANXIETY |
475 |
0.0017 |
| 325 |
HEAVY MENSTRUAL BLEEDING |
15 |
0.0017 |
| 326 |
WEIGHT ABNORMAL |
4 |
0.0017 |
| 327 |
LEARNING DISORDER |
4 |
0.0017 |
| 328 |
THERAPEUTIC RESPONSE SHORTENED |
55 |
0.0017 |
| 329 |
WRONG DOSE |
4 |
0.0017 |
| 330 |
DEPRESSION |
376 |
0.0017 |
| 331 |
MAJOR DEPRESSION |
12 |
0.0016 |
| 332 |
BREATH ODOUR |
4 |
0.0016 |
| 333 |
CONDUCTION DISORDER |
3 |
0.0016 |
| 334 |
HALLUCINATION, AUDITORY |
26 |
0.0016 |
| 335 |
EMOTIONAL DISORDER |
50 |
0.0016 |
| 336 |
IMPATIENCE |
3 |
0.0016 |
| 337 |
DYSGEUSIA |
118 |
0.0016 |
| 338 |
EXPOSURE VIA INGESTION |
4 |
0.0016 |
| 339 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
71 |
0.0016 |
| 340 |
RETINAL ARTERY OCCLUSION |
4 |
0.0016 |
| 341 |
HYPERAESTHESIA |
13 |
0.0016 |
| 342 |
IRIDOCYCLITIS |
5 |
0.0016 |
| 343 |
EXPOSURE TO TOXIC AGENT |
5 |
0.0016 |
| 344 |
PANIC DISORDER |
6 |
0.0015 |
| 345 |
CONVERSION DISORDER |
3 |
0.0015 |
| 346 |
PRODUCT SUPPLY ISSUE |
11 |
0.0015 |
| 347 |
RESTLESSNESS |
56 |
0.0015 |
| 348 |
SEDATION |
40 |
0.0015 |
| 349 |
PERSONALITY DISORDER |
4 |
0.0015 |
| 350 |
DYSKINESIA |
62 |
0.0015 |
| 351 |
ADVERSE DRUG REACTION |
136 |
0.0015 |
| 352 |
MOOD SWINGS |
48 |
0.0015 |
| 353 |
GASTRITIS EROSIVE |
7 |
0.0015 |
| 354 |
ARTERIOSPASM CORONARY |
6 |
0.0015 |
| 355 |
CARDIAC DISCOMFORT |
3 |
0.0015 |
| 356 |
MUSCLE TIGHTNESS |
24 |
0.0015 |
| 357 |
GAMBLING DISORDER |
4 |
0.0015 |
| 358 |
SLEEP DISORDER |
104 |
0.0015 |
| 359 |
SOMNOLENCE |
292 |
0.0014 |
| 360 |
PLEURITIC PAIN |
4 |
0.0014 |
| 361 |
DRUG-INDUCED LIVER INJURY |
45 |
0.0014 |
| 362 |
MUSCLE TWITCHING |
33 |
0.0014 |
| 363 |
DRUG TOLERANCE DECREASED |
4 |
0.0014 |
| 364 |
ALANINE AMINOTRANSFERASE ABNORMAL |
3 |
0.0014 |
| 365 |
HANGOVER |
5 |
0.0014 |
| 366 |
INTENTIONAL PRODUCT USE ISSUE |
124 |
0.0014 |
| 367 |
MENTAL DISORDER |
61 |
0.0014 |
| 368 |
NEUROLOGICAL SYMPTOM |
8 |
0.0014 |
| 369 |
DYSTONIA |
27 |
0.0014 |
| 370 |
PRODUCT SOLUBILITY ABNORMAL |
7 |
0.0014 |
| 371 |
ARTHRITIS |
109 |
0.0014 |
| 372 |
PRODUCT USE ISSUE |
260 |
0.0014 |
| 373 |
METABOLIC DISORDER |
8 |
0.0014 |
| 374 |
UTERINE LEIOMYOMA |
10 |
0.0014 |
| 375 |
BIPOLAR I DISORDER |
3 |
0.0014 |
| 376 |
ACCIDENT AT WORK |
3 |
0.0014 |
| 377 |
POISONING |
17 |
0.0014 |
| 378 |
ABNORMAL BEHAVIOUR |
53 |
0.0013 |
| 379 |
COMPLETED SUICIDE |
111 |
0.0013 |
| 380 |
DRUG INTERACTION |
211 |
0.0013 |
| 381 |
MENTAL IMPAIRMENT |
32 |
0.0013 |
| 382 |
PERIPHERAL COLDNESS |
18 |
0.0013 |
| 383 |
COMMUNICATION DISORDER |
5 |
0.0013 |
| 384 |
RESPIRATORY DEPRESSION |
16 |
0.0013 |
| 385 |
FORMICATION |
9 |
0.0013 |
| 386 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
232 |
0.0013 |
| 387 |
HEPATIC ENCEPHALOPATHY |
12 |
0.0013 |
| 388 |
EPSTEIN-BARR VIRUS INFECTION |
8 |
0.0013 |
| 389 |
SLUGGISHNESS |
13 |
0.0013 |
| 390 |
TACHYCARDIA |
113 |
0.0013 |
| 391 |
QUALITY OF LIFE DECREASED |
17 |
0.0013 |
| 392 |
ANGIOPATHY |
7 |
0.0012 |
| 393 |
MIOSIS |
10 |
0.0012 |
| 394 |
CONFUSIONAL STATE |
201 |
0.0012 |
| 395 |
NEUTROPHILIA |
7 |
0.0012 |
| 396 |
LYMPHOCYTE COUNT INCREASED |
4 |
0.0012 |
| 397 |
THERAPY PARTIAL RESPONDER |
19 |
0.0012 |
| 398 |
LISTLESS |
4 |
0.0012 |
| 399 |
FEELING DRUNK |
9 |
0.0012 |
| 400 |
PULMONARY EMBOLISM |
114 |
0.0012 |
| 401 |
HYPOTHERMIA |
12 |
0.0012 |
| 402 |
SUPRAVENTRICULAR EXTRASYSTOLES |
4 |
0.0012 |
| 403 |
PRODUCT LABEL ISSUE |
8 |
0.0012 |
| 404 |
HYPERTHERMIA |
9 |
0.0012 |
| 405 |
TONGUE DISCOMFORT |
5 |
0.0012 |
| 406 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
8 |
0.0012 |
| 407 |
HEPATIC PAIN |
5 |
0.0012 |
| 408 |
VITAMIN D DECREASED |
10 |
0.0012 |
| 409 |
INITIAL INSOMNIA |
12 |
0.0012 |
| 410 |
ALCOHOLISM |
5 |
0.0012 |
| 411 |
CEREBRAL ISCHAEMIA |
6 |
0.0012 |
| 412 |
SPEECH DISORDER |
61 |
0.0012 |
| 413 |
DELUSION |
18 |
0.0012 |
| 414 |
DEPRESSION SUICIDAL |
4 |
0.0012 |
| 415 |
SCHIZOPHRENIA |
14 |
0.0012 |
| 416 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
7 |
0.0011 |
| 417 |
VENTRICULAR TACHYCARDIA |
19 |
0.0011 |
| 418 |
PLATELET COUNT INCREASED |
15 |
0.0011 |
| 419 |
TENSION |
7 |
0.0011 |
| 420 |
MALABSORPTION |
6 |
0.0011 |
| 421 |
DYSPHEMIA |
5 |
0.0011 |
| 422 |
INSOMNIA |
303 |
0.0011 |
| 423 |
CARDIOTOXICITY |
10 |
0.0011 |
| 424 |
DISABILITY |
22 |
0.0011 |
| 425 |
ELECTROCARDIOGRAM QT PROLONGED |
40 |
0.0011 |
| 426 |
CLUMSINESS |
3 |
0.0011 |
| 427 |
CONDITION AGGRAVATED |
334 |
0.0011 |
| 428 |
VENTRICULAR ARRHYTHMIA |
4 |
0.0011 |
| 429 |
RESPIRATORY ARREST |
30 |
0.0011 |
| 430 |
DRUG LEVEL INCREASED |
18 |
0.0011 |
| 431 |
TOXICITY TO VARIOUS AGENTS |
183 |
0.0011 |
| 432 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
6 |
0.0011 |
| 433 |
BLOOD PRESSURE DIASTOLIC INCREASED |
5 |
0.0011 |
| 434 |
CARDIAC FLUTTER |
7 |
0.0011 |
| 435 |
INTERMENSTRUAL BLEEDING |
6 |
0.0011 |
| 436 |
SNORING |
4 |
0.0011 |
| 437 |
AUTOIMMUNE THYROIDITIS |
4 |
0.0011 |
| 438 |
MICTURITION URGENCY |
12 |
0.0010 |
| 439 |
THERAPY INTERRUPTED |
75 |
0.0010 |
| 440 |
ENDOMETRIOSIS |
5 |
0.0010 |
| 441 |
POST-TRAUMATIC STRESS DISORDER |
7 |
0.0010 |
| 442 |
PANIC ATTACK |
38 |
0.0010 |
| 443 |
MOUTH SWELLING |
6 |
0.0010 |
| 444 |
HEART RATE INCREASED |
103 |
0.0010 |
| 445 |
BLOOD PARATHYROID HORMONE INCREASED |
3 |
0.0010 |
| 446 |
APHASIA |
31 |
0.0010 |
| 447 |
BRADYKINESIA |
6 |
0.0010 |
| 448 |
GLUCOSE TOLERANCE IMPAIRED |
6 |
0.0010 |
| 449 |
FEAR |
27 |
0.0010 |
| 450 |
HEPATIC ENZYME ABNORMAL |
5 |
0.0010 |
| 451 |
ARRHYTHMIA |
47 |
0.0010 |
| 452 |
FEELING ABNORMAL |
237 |
0.0010 |
| 453 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
5 |
0.0010 |
| 454 |
PHARYNGITIS |
12 |
0.0010 |
| 455 |
COLD SWEAT |
17 |
0.0010 |
| 456 |
CARDIO-RESPIRATORY ARREST |
40 |
0.0010 |
| 457 |
ABDOMINAL DISCOMFORT |
160 |
0.0010 |
| 458 |
PAIN IN JAW |
27 |
0.0010 |
| 459 |
FOREIGN BODY IN THROAT |
3 |
0.0010 |
| 460 |
FOOD CRAVING |
5 |
0.0009 |
| 461 |
DRUG ABUSE |
79 |
0.0009 |
| 462 |
BLADDER PAIN |
3 |
0.0009 |
| 463 |
RENAL PAIN |
10 |
0.0009 |
| 464 |
INCREASED APPETITE |
18 |
0.0009 |
| 465 |
HYPERSOMNIA |
27 |
0.0009 |
| 466 |
DRY MOUTH |
75 |
0.0009 |
| 467 |
ANGINA UNSTABLE |
6 |
0.0009 |
| 468 |
HEPATITIS ACUTE |
6 |
0.0009 |
| 469 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
4 |
0.0009 |
| 470 |
MYOCLONUS |
11 |
0.0009 |
| 471 |
MUSCLE RIGIDITY |
11 |
0.0009 |
| 472 |
HEAD DISCOMFORT |
16 |
0.0009 |
| 473 |
SALIVARY HYPERSECRETION |
9 |
0.0009 |
| 474 |
HYPERTHYROIDISM |
13 |
0.0009 |
| 475 |
LOSS OF LIBIDO |
8 |
0.0009 |
| 476 |
DRUG INEFFECTIVE |
1170 |
0.0009 |
| 477 |
UNEVALUABLE EVENT |
67 |
0.0009 |
| 478 |
HEMIPARESIS |
15 |
0.0009 |
| 479 |
SUSPECTED OFF LABEL USE |
4 |
0.0009 |
| 480 |
HYPERHIDROSIS |
114 |
0.0009 |
| 481 |
NERVOUSNESS |
46 |
0.0009 |
| 482 |
IMPAIRED DRIVING ABILITY |
10 |
0.0009 |
| 483 |
URINARY INCONTINENCE |
26 |
0.0009 |
| 484 |
INFARCTION |
6 |
0.0009 |
| 485 |
HAEMORRHAGE INTRACRANIAL |
13 |
0.0009 |
| 486 |
COVID-19 |
152 |
0.0009 |
| 487 |
PRODUCT DISTRIBUTION ISSUE |
8 |
0.0009 |
| 488 |
HALLUCINATION, VISUAL |
18 |
0.0009 |
| 489 |
PRODUCT USE IN UNAPPROVED INDICATION |
211 |
0.0009 |
| 490 |
LETHARGY |
48 |
0.0008 |
| 491 |
TYPE 1 DIABETES MELLITUS |
5 |
0.0008 |
| 492 |
GUILLAIN-BARRE SYNDROME |
4 |
0.0008 |
| 493 |
CIRCULATORY COLLAPSE |
14 |
0.0008 |
| 494 |
ABDOMINAL TENDERNESS |
4 |
0.0008 |
| 495 |
PRODUCT QUALITY ISSUE |
109 |
0.0008 |
| 496 |
BLEPHAROSPASM |
5 |
0.0008 |
| 497 |
GENERALISED TONIC-CLONIC SEIZURE |
13 |
0.0008 |
| 498 |
SUBARACHNOID HAEMORRHAGE |
8 |
0.0008 |
| 499 |
ERECTILE DYSFUNCTION |
20 |
0.0008 |
| 500 |
ANAL INCONTINENCE |
7 |
0.0008 |
| 501 |
HEADACHE |
485 |
0.0008 |
| 502 |
FAECES HARD |
3 |
0.0008 |
| 503 |
WEIGHT DECREASED |
215 |
0.0008 |
| 504 |
EXTRAPYRAMIDAL DISORDER |
19 |
0.0008 |
| 505 |
PRODUCT ODOUR ABNORMAL |
8 |
0.0008 |
| 506 |
CYANOSIS |
12 |
0.0008 |
| 507 |
SOMNAMBULISM |
5 |
0.0008 |
| 508 |
TREATMENT FAILURE |
63 |
0.0008 |
| 509 |
BLOOD LACTIC ACID INCREASED |
4 |
0.0008 |
| 510 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
30 |
0.0008 |
| 511 |
DISORIENTATION |
30 |
0.0008 |
| 512 |
OBESITY |
12 |
0.0008 |
| 513 |
EAR INFECTION |
20 |
0.0008 |
| 514 |
PRODUCT SIZE ISSUE |
4 |
0.0007 |
| 515 |
AMENORRHOEA |
13 |
0.0007 |
| 516 |
CEREBROVASCULAR ACCIDENT |
124 |
0.0007 |
| 517 |
EYE MOVEMENT DISORDER |
5 |
0.0007 |
| 518 |
COGNITIVE DISORDER |
34 |
0.0007 |
| 519 |
ENCEPHALITIS |
5 |
0.0007 |
| 520 |
DELIRIUM |
25 |
0.0007 |
| 521 |
MENTAL STATUS CHANGES |
20 |
0.0007 |
| 522 |
ORAL DISCOMFORT |
10 |
0.0007 |
| 523 |
EXTRASYSTOLES |
5 |
0.0007 |
| 524 |
DRUG USE DISORDER |
6 |
0.0007 |
| 525 |
COELIAC DISEASE |
7 |
0.0007 |
| 526 |
INTESTINAL STENOSIS |
3 |
0.0007 |
| 527 |
FACIAL PARALYSIS |
6 |
0.0007 |
| 528 |
BACTERIAL INFECTION |
13 |
0.0007 |
| 529 |
DRUG DEPENDENCE |
110 |
0.0007 |
| 530 |
LYMPHOCYTE COUNT DECREASED |
12 |
0.0007 |
| 531 |
BLOOD CREATINE INCREASED |
3 |
0.0007 |
| 532 |
SINUS HEADACHE |
4 |
0.0007 |
| 533 |
SYMPTOM RECURRENCE |
4 |
0.0007 |
| 534 |
FATIGUE |
518 |
0.0007 |
| 535 |
PRODUCT TASTE ABNORMAL |
9 |
0.0007 |
| 536 |
URINARY RETENTION |
22 |
0.0007 |
| 537 |
MEMORY IMPAIRMENT |
90 |
0.0007 |
| 538 |
EPILEPSY |
20 |
0.0007 |
| 539 |
BUNDLE BRANCH BLOCK RIGHT |
3 |
0.0007 |
| 540 |
ABNORMAL DREAMS |
18 |
0.0007 |
| 541 |
PREGNANCY |
13 |
0.0006 |
| 542 |
MULTIPLE ALLERGIES |
5 |
0.0006 |
| 543 |
HALLUCINATION |
48 |
0.0006 |
| 544 |
GASTROINTESTINAL PAIN |
7 |
0.0006 |
| 545 |
BLOOD PROLACTIN INCREASED |
3 |
0.0006 |
| 546 |
SEASONAL ALLERGY |
9 |
0.0006 |
| 547 |
HYPERTENSIVE CRISIS |
7 |
0.0006 |
| 548 |
VISION BLURRED |
86 |
0.0006 |
| 549 |
SENSORY DISTURBANCE |
10 |
0.0006 |
| 550 |
GALACTORRHOEA |
4 |
0.0006 |
| 551 |
TREMOR |
103 |
0.0006 |
| 552 |
ERUCTATION |
12 |
0.0006 |
| 553 |
DECREASED APPETITE |
144 |
0.0006 |
| 554 |
UNRESPONSIVE TO STIMULI |
16 |
0.0006 |
| 555 |
SYNCOPE |
62 |
0.0006 |
| 556 |
INCOHERENT |
4 |
0.0006 |
| 557 |
HYPERPROLACTINAEMIA |
4 |
0.0006 |
| 558 |
PRESYNCOPE |
15 |
0.0006 |
| 559 |
SUBSTANCE ABUSE |
5 |
0.0006 |
| 560 |
THERAPY CHANGE |
6 |
0.0006 |
| 561 |
PRODUCT PREPARATION ISSUE |
4 |
0.0006 |
| 562 |
BEDRIDDEN |
8 |
0.0006 |
| 563 |
PHOTOSENSITIVITY REACTION |
10 |
0.0006 |
| 564 |
TARDIVE DYSKINESIA |
17 |
0.0006 |
| 565 |
BRAIN INJURY |
6 |
0.0006 |
| 566 |
SPLENOMEGALY |
7 |
0.0006 |
| 567 |
LEFT VENTRICULAR DYSFUNCTION |
4 |
0.0006 |
| 568 |
PRODUCT PRESCRIBING ISSUE |
13 |
0.0006 |
| 569 |
INTENTIONAL DOSE OMISSION |
17 |
0.0006 |
| 570 |
FEEDING DISORDER |
12 |
0.0006 |
| 571 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
17 |
0.0006 |
| 572 |
NEUROLEPTIC MALIGNANT SYNDROME |
7 |
0.0006 |
| 573 |
PHOTOPHOBIA |
11 |
0.0006 |
| 574 |
INCREASED UPPER AIRWAY SECRETION |
3 |
0.0006 |
| 575 |
TEMPERATURE INTOLERANCE |
6 |
0.0006 |
| 576 |
RESPIRATION ABNORMAL |
4 |
0.0006 |
| 577 |
DRUG INTOLERANCE |
56 |
0.0006 |
| 578 |
HYPERBILIRUBINAEMIA |
6 |
0.0006 |
| 579 |
APLASTIC ANAEMIA |
3 |
0.0006 |
| 580 |
LYMPHADENOPATHY |
20 |
0.0006 |
| 581 |
CARDIAC ARREST |
46 |
0.0006 |
| 582 |
HAEMATOCRIT DECREASED |
11 |
0.0006 |
| 583 |
PARAESTHESIA ORAL |
8 |
0.0006 |
| 584 |
OROPHARYNGEAL DISCOMFORT |
5 |
0.0006 |
| 585 |
PALLOR |
15 |
0.0006 |
| 586 |
ASPIRATION |
6 |
0.0005 |
| 587 |
PSYCHIATRIC SYMPTOM |
4 |
0.0005 |
| 588 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
12 |
0.0005 |
| 589 |
HYPOPHOSPHATAEMIA |
4 |
0.0005 |
| 590 |
SUNBURN |
4 |
0.0005 |
| 591 |
MIDDLE INSOMNIA |
10 |
0.0005 |
| 592 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
4 |
0.0005 |
| 593 |
CEREBRAL INFARCTION |
13 |
0.0005 |
| 594 |
ABORTION INDUCED |
5 |
0.0005 |
| 595 |
LOSS OF CONSCIOUSNESS |
68 |
0.0005 |
| 596 |
DYSMENORRHOEA |
7 |
0.0005 |
| 597 |
CHEST DISCOMFORT |
54 |
0.0005 |
| 598 |
DERMATITIS |
11 |
0.0005 |
| 599 |
FEELING HOT |
32 |
0.0005 |
| 600 |
EXERCISE TOLERANCE DECREASED |
3 |
0.0005 |
| 601 |
FOOD ALLERGY |
4 |
0.0005 |
| 602 |
HYPERVENTILATION |
3 |
0.0005 |
| 603 |
ORTHOSTATIC HYPOTENSION |
9 |
0.0005 |
| 604 |
CONCUSSION |
4 |
0.0005 |
| 605 |
EATING DISORDER |
11 |
0.0005 |
| 606 |
TACHYPNOEA |
7 |
0.0005 |
| 607 |
AUTOIMMUNE DISORDER |
5 |
0.0005 |
| 608 |
HAEMATEMESIS |
13 |
0.0005 |
| 609 |
PAIN IN EXTREMITY |
151 |
0.0005 |
| 610 |
ELECTROCARDIOGRAM ABNORMAL |
4 |
0.0005 |
| 611 |
ENERGY INCREASED |
3 |
0.0005 |
| 612 |
DRUG SCREEN POSITIVE |
4 |
0.0005 |
| 613 |
PRODUCT DISPENSING ERROR |
11 |
0.0005 |
| 614 |
PRODUCT PRESCRIBING ERROR |
12 |
0.0005 |
| 615 |
GASTROINTESTINAL DISORDER |
45 |
0.0005 |
| 616 |
PYREXIA |
172 |
0.0005 |
| 617 |
LACTIC ACIDOSIS |
16 |
0.0005 |
| 618 |
SEIZURE |
57 |
0.0005 |
| 619 |
PANCREATITIS ACUTE |
11 |
0.0005 |
| 620 |
LIMB DISCOMFORT |
15 |
0.0005 |
| 621 |
EOSINOPHIL COUNT INCREASED |
4 |
0.0005 |
| 622 |
TREATMENT NONCOMPLIANCE |
26 |
0.0005 |
| 623 |
SENSATION OF FOREIGN BODY |
4 |
0.0005 |
| 624 |
THERAPEUTIC RESPONSE UNEXPECTED |
21 |
0.0005 |
| 625 |
NECK PAIN |
26 |
0.0005 |
| 626 |
ECONOMIC PROBLEM |
7 |
0.0005 |
| 627 |
OESOPHAGITIS |
5 |
0.0005 |
| 628 |
OVERDOSE |
98 |
0.0005 |
| 629 |
DYSARTHRIA |
17 |
0.0005 |
| 630 |
FOOT DEFORMITY |
5 |
0.0005 |
| 631 |
RESPIRATORY RATE INCREASED |
4 |
0.0005 |
| 632 |
EJECTION FRACTION DECREASED |
7 |
0.0004 |
| 633 |
ENCEPHALOPATHY |
11 |
0.0004 |
| 634 |
AMNESIA |
29 |
0.0004 |
| 635 |
OCULAR DISCOMFORT |
5 |
0.0004 |
| 636 |
PRODUCT USE COMPLAINT |
7 |
0.0004 |
| 637 |
BODY TEMPERATURE INCREASED |
9 |
0.0004 |
| 638 |
ABNORMAL LOSS OF WEIGHT |
3 |
0.0004 |
| 639 |
PREMATURE DELIVERY |
7 |
0.0004 |
| 640 |
MYOCARDITIS |
5 |
0.0004 |
| 641 |
MOVEMENT DISORDER |
14 |
0.0004 |
| 642 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
31 |
0.0004 |
| 643 |
BRAIN NEOPLASM |
4 |
0.0004 |
| 644 |
SKIN DISCOLOURATION |
20 |
0.0004 |
| 645 |
INTENTIONAL PRODUCT MISUSE |
38 |
0.0004 |
| 646 |
BLOOD GLUCOSE ABNORMAL |
8 |
0.0004 |
| 647 |
AUTOIMMUNE HEPATITIS |
3 |
0.0004 |
| 648 |
ELECTROLYTE IMBALANCE |
5 |
0.0004 |
| 649 |
CONTRAINDICATED PRODUCT ADMINISTERED |
13 |
0.0004 |
| 650 |
APPENDICITIS |
4 |
0.0004 |
| 651 |
DEFAECATION URGENCY |
3 |
0.0004 |
| 652 |
FLANK PAIN |
4 |
0.0004 |
| 653 |
MATERNAL EXPOSURE DURING PREGNANCY |
38 |
0.0004 |
| 654 |
OROPHARYNGEAL PAIN |
39 |
0.0004 |
| 655 |
DIZZINESS |
210 |
0.0004 |
| 656 |
PRODUCT PACKAGING ISSUE |
4 |
0.0004 |
| 657 |
SLEEP APNOEA SYNDROME |
8 |
0.0004 |
| 658 |
ANGINA PECTORIS |
12 |
0.0004 |
| 659 |
ACCIDENT |
5 |
0.0004 |
| 660 |
BLOOD PRESSURE FLUCTUATION |
10 |
0.0004 |
| 661 |
CHEST PAIN |
77 |
0.0004 |
| 662 |
HYPERTENSION |
88 |
0.0004 |
| 663 |
ALTERED STATE OF CONSCIOUSNESS |
9 |
0.0004 |
| 664 |
BRADYCARDIA |
22 |
0.0004 |
| 665 |
OFF LABEL USE |
363 |
0.0004 |
| 666 |
HYPOKINESIA |
6 |
0.0004 |
| 667 |
DIZZINESS POSTURAL |
4 |
0.0004 |
| 668 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
7 |
0.0004 |
| 669 |
DRUG WITHDRAWAL SYNDROME |
36 |
0.0004 |
| 670 |
SCAR |
7 |
0.0004 |
| 671 |
PHARYNGEAL SWELLING |
4 |
0.0004 |
| 672 |
ILLNESS |
42 |
0.0004 |
| 673 |
METABOLIC ACIDOSIS |
13 |
0.0004 |
| 674 |
WEIGHT INCREASED |
91 |
0.0004 |
| 675 |
ROAD TRAFFIC ACCIDENT |
17 |
0.0004 |
| 676 |
BODY TEMPERATURE DECREASED |
4 |
0.0004 |
| 677 |
HYPOAESTHESIA |
60 |
0.0004 |
| 678 |
COMA |
19 |
0.0004 |
| 679 |
COLITIS |
15 |
0.0004 |
| 680 |
PRODUCT DOSE OMISSION ISSUE |
116 |
0.0004 |
| 681 |
ACIDOSIS |
3 |
0.0004 |
| 682 |
BLOOD PRESSURE INCREASED |
60 |
0.0004 |
| 683 |
THIRST |
7 |
0.0004 |
| 684 |
BLOOD PRESSURE DECREASED |
26 |
0.0004 |
| 685 |
ADVERSE EVENT |
36 |
0.0004 |
| 686 |
HYPOKALAEMIA |
18 |
0.0004 |
| 687 |
ANKLE FRACTURE |
6 |
0.0004 |
| 688 |
APHTHOUS ULCER |
3 |
0.0004 |
| 689 |
BLOOD CHOLESTEROL INCREASED |
18 |
0.0004 |
| 690 |
APNOEA |
3 |
0.0004 |
| 691 |
PULMONARY OEDEMA |
17 |
0.0004 |
| 692 |
HYPOTENSION |
76 |
0.0004 |
| 693 |
RASH |
165 |
0.0004 |
| 694 |
JOINT DISLOCATION |
4 |
0.0004 |
| 695 |
HEPATIC STEATOSIS |
7 |
0.0004 |
| 696 |
SURGERY |
22 |
0.0004 |
| 697 |
NAUSEA |
294 |
0.0004 |
| 698 |
DECREASED ACTIVITY |
4 |
0.0004 |
| 699 |
MYALGIA |
63 |
0.0004 |
| 700 |
THERAPY CESSATION |
19 |
0.0004 |
| 701 |
PHARYNGITIS STREPTOCOCCAL |
4 |
0.0004 |
| 702 |
IMPAIRED GASTRIC EMPTYING |
5 |
0.0004 |
| 703 |
EYE DISORDER |
12 |
0.0004 |
| 704 |
EMBOLISM |
3 |
0.0004 |
| 705 |
NO ADVERSE EVENT |
65 |
0.0004 |
| 706 |
ORAL PAIN |
8 |
0.0004 |
| 707 |
FISTULA |
4 |
0.0004 |
| 708 |
CANDIDA INFECTION |
6 |
0.0004 |
| 709 |
SKIN REACTION |
5 |
0.0004 |
| 710 |
CARDIOVASCULAR DISORDER |
9 |
0.0004 |
| 711 |
PRODUCT DOSE OMISSION IN ERROR |
10 |
0.0004 |
| 712 |
HEPATITIS |
9 |
0.0004 |
| 713 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
71 |
0.0004 |
| 714 |
RED BLOOD CELL COUNT DECREASED |
10 |
0.0003 |
| 715 |
PARALYSIS |
5 |
0.0003 |
| 716 |
EXTRA DOSE ADMINISTERED |
14 |
0.0003 |
| 717 |
TASTE DISORDER |
7 |
0.0003 |
| 718 |
HYPOTHYROIDISM |
11 |
0.0003 |
| 719 |
ANHEDONIA |
9 |
0.0003 |
| 720 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
6 |
0.0003 |
| 721 |
MUSCLE SPASMS |
62 |
0.0003 |
| 722 |
BLOOD IRON DECREASED |
4 |
0.0003 |
| 723 |
RHABDOMYOLYSIS |
14 |
0.0003 |
| 724 |
RASH ERYTHEMATOUS |
16 |
0.0003 |
| 725 |
GASTROENTERITIS VIRAL |
6 |
0.0003 |
| 726 |
HYPOAESTHESIA ORAL |
5 |
0.0003 |
| 727 |
VIRAL INFECTION |
11 |
0.0003 |
| 728 |
EMOTIONAL DISTRESS |
40 |
0.0003 |
| 729 |
FIBROMYALGIA |
8 |
0.0003 |
| 730 |
HIDRADENITIS |
3 |
0.0003 |
| 731 |
DISCOMFORT |
20 |
0.0003 |
| 732 |
FLUSHING |
33 |
0.0003 |
| 733 |
ABORTION SPONTANEOUS |
13 |
0.0003 |
| 734 |
INTERVERTEBRAL DISC DEGENERATION |
3 |
0.0003 |
| 735 |
CONJUNCTIVITIS |
6 |
0.0003 |
| 736 |
VAGINAL HAEMORRHAGE |
14 |
0.0003 |
| 737 |
DIARRHOEA HAEMORRHAGIC |
3 |
0.0003 |
| 738 |
ARTERIOSCLEROSIS |
3 |
0.0003 |
| 739 |
PAIN |
195 |
0.0003 |
| 740 |
EYE INFLAMMATION |
3 |
0.0003 |
| 741 |
ULCER |
5 |
0.0003 |
| 742 |
HYPOXIA |
11 |
0.0003 |
| 743 |
ACUTE RESPIRATORY FAILURE |
6 |
0.0003 |
| 744 |
PRESCRIBED OVERDOSE |
6 |
0.0003 |
| 745 |
HEART RATE IRREGULAR |
7 |
0.0003 |
| 746 |
EAR PAIN |
6 |
0.0003 |
| 747 |
EMBEDDED DEVICE |
3 |
0.0003 |
| 748 |
SARS-COV-2 TEST POSITIVE |
4 |
0.0003 |
| 749 |
C-REACTIVE PROTEIN INCREASED |
11 |
0.0003 |
| 750 |
BLADDER DISORDER |
3 |
0.0003 |
| 751 |
BLOOD PRESSURE ABNORMAL |
6 |
0.0003 |
| 752 |
DYSURIA |
11 |
0.0003 |
| 753 |
MENSTRUATION IRREGULAR |
8 |
0.0003 |
| 754 |
VISUAL IMPAIRMENT |
37 |
0.0003 |
| 755 |
THROAT TIGHTNESS |
8 |
0.0003 |
| 756 |
DRY THROAT |
3 |
0.0003 |
| 757 |
DRUG LEVEL DECREASED |
3 |
0.0003 |
| 758 |
ABDOMINAL PAIN |
68 |
0.0003 |
| 759 |
DIABETES MELLITUS |
22 |
0.0003 |
| 760 |
NERVOUS SYSTEM DISORDER |
9 |
0.0003 |
| 761 |
MOUTH ULCERATION |
6 |
0.0003 |
| 762 |
FULL BLOOD COUNT ABNORMAL |
3 |
0.0003 |
| 763 |
BLOOD TRIGLYCERIDES INCREASED |
5 |
0.0003 |
| 764 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
8 |
0.0003 |
| 765 |
DIABETES MELLITUS INADEQUATE CONTROL |
5 |
0.0003 |
| 766 |
FLATULENCE |
16 |
0.0003 |
| 767 |
RETCHING |
6 |
0.0003 |
| 768 |
BREAST PAIN |
3 |
0.0003 |
| 769 |
BODY HEIGHT DECREASED |
3 |
0.0003 |
| 770 |
ISCHAEMIC STROKE |
5 |
0.0003 |
| 771 |
LEUKOPENIA |
14 |
0.0003 |
| 772 |
PARAESTHESIA |
44 |
0.0003 |
| 773 |
HEREDITARY ANGIOEDEMA |
3 |
0.0003 |
| 774 |
NIGHT SWEATS |
9 |
0.0003 |
| 775 |
BALANCE DISORDER |
24 |
0.0003 |
| 776 |
LEUKOCYTOSIS |
5 |
0.0003 |
| 777 |
DYSPEPSIA |
27 |
0.0003 |
| 778 |
MELAENA |
6 |
0.0003 |
| 779 |
CARDIOMYOPATHY |
4 |
0.0003 |
| 780 |
SKIN HAEMORRHAGE |
4 |
0.0003 |
| 781 |
RESPIRATORY TRACT INFECTION |
7 |
0.0003 |
| 782 |
ABDOMINAL DISTENSION |
28 |
0.0003 |
| 783 |
CHROMATURIA |
6 |
0.0003 |
| 784 |
PREMATURE BABY |
8 |
0.0003 |
| 785 |
POLLAKIURIA |
11 |
0.0003 |
| 786 |
FOOT FRACTURE |
5 |
0.0003 |
| 787 |
WHITE BLOOD CELL COUNT INCREASED |
10 |
0.0003 |
| 788 |
MALAISE |
114 |
0.0003 |
| 789 |
GLAUCOMA |
5 |
0.0003 |
| 790 |
HYPERSENSITIVITY |
48 |
0.0003 |
| 791 |
INCORRECT DOSE ADMINISTERED |
59 |
0.0003 |
| 792 |
FOETAL EXPOSURE DURING PREGNANCY |
21 |
0.0003 |
| 793 |
DYSPHONIA |
15 |
0.0003 |
| 794 |
HAEMORRHOIDS |
5 |
0.0003 |
| 795 |
HEART RATE DECREASED |
9 |
0.0003 |
| 796 |
CHOKING |
5 |
0.0003 |
| 797 |
HEAD INJURY |
8 |
0.0003 |
| 798 |
FEELING COLD |
7 |
0.0003 |
| 799 |
VOMITING |
117 |
0.0002 |
| 800 |
HYPONATRAEMIA |
14 |
0.0002 |
| 801 |
ABDOMINAL PAIN UPPER |
51 |
0.0002 |
| 802 |
PRODUCT ADMINISTRATION ERROR |
5 |
0.0002 |
| 803 |
ASTHENIA |
93 |
0.0002 |
| 804 |
THROAT IRRITATION |
11 |
0.0002 |
| 805 |
THERAPY NON-RESPONDER |
11 |
0.0002 |
| 806 |
LIVER INJURY |
6 |
0.0002 |
| 807 |
EXPOSURE DURING PREGNANCY |
15 |
0.0002 |
| 808 |
COAGULOPATHY |
4 |
0.0002 |
| 809 |
DYSSTASIA |
7 |
0.0002 |
| 810 |
ACUTE MYOCARDIAL INFARCTION |
7 |
0.0002 |
| 811 |
ANAPHYLACTIC REACTION |
13 |
0.0002 |
| 812 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
4 |
0.0002 |
| 813 |
IRRITABLE BOWEL SYNDROME |
5 |
0.0002 |
| 814 |
MUSCULOSKELETAL DISCOMFORT |
4 |
0.0002 |
| 815 |
LACRIMATION INCREASED |
7 |
0.0002 |
| 816 |
INJECTION SITE RASH |
7 |
0.0002 |
| 817 |
GASTRITIS |
6 |
0.0002 |
| 818 |
GYNAECOMASTIA |
7 |
0.0002 |
| 819 |
GLOSSODYNIA |
5 |
0.0002 |
| 820 |
JAUNDICE |
6 |
0.0002 |
| 821 |
RASH PRURITIC |
12 |
0.0002 |
| 822 |
TOOTHACHE |
4 |
0.0002 |
| 823 |
CONSTIPATION |
48 |
0.0002 |
| 824 |
SKIN LESION |
6 |
0.0002 |
| 825 |
NEPHROLITHIASIS |
10 |
0.0002 |
| 826 |
URTICARIA |
36 |
0.0002 |
| 827 |
WOUND |
6 |
0.0002 |
| 828 |
CHOLELITHIASIS |
7 |
0.0002 |
| 829 |
SKIN EXFOLIATION |
18 |
0.0002 |
| 830 |
EYE PAIN |
12 |
0.0002 |
| 831 |
ALANINE AMINOTRANSFERASE INCREASED |
13 |
0.0002 |
| 832 |
MUSCULAR WEAKNESS |
24 |
0.0002 |
| 833 |
ACNE |
16 |
0.0002 |
| 834 |
DERMATITIS ATOPIC |
11 |
0.0002 |
| 835 |
NEURALGIA |
5 |
0.0002 |
| 836 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
11 |
0.0002 |
| 837 |
DRY EYE |
10 |
0.0002 |
| 838 |
HEPATIC FAILURE |
6 |
0.0002 |
| 839 |
CONTUSION |
19 |
0.0002 |
| 840 |
HYPOPHAGIA |
5 |
0.0002 |
| 841 |
CEREBRAL HAEMORRHAGE |
7 |
0.0002 |
| 842 |
DRUG RESISTANCE |
5 |
0.0002 |
| 843 |
INFLAMMATION |
10 |
0.0002 |
| 844 |
DIPLOPIA |
5 |
0.0002 |
| 845 |
GENERAL PHYSICAL HEALTH DETERIORATION |
22 |
0.0002 |
| 846 |
DYSPNOEA |
106 |
0.0002 |
| 847 |
INTESTINAL OBSTRUCTION |
7 |
0.0002 |
| 848 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
4 |
0.0002 |
| 849 |
DEPENDENCE |
10 |
0.0002 |
| 850 |
HOSPITALISATION |
28 |
0.0002 |
| 851 |
SKIN BURNING SENSATION |
13 |
0.0002 |
| 852 |
BACK PAIN |
42 |
0.0002 |
| 853 |
TRANSAMINASES INCREASED |
4 |
0.0002 |
| 854 |
FACE OEDEMA |
3 |
0.0002 |
| 855 |
PSORIATIC ARTHROPATHY |
7 |
0.0002 |
| 856 |
BLINDNESS |
7 |
0.0002 |
| 857 |
MUSCULOSKELETAL STIFFNESS |
15 |
0.0002 |
| 858 |
EOSINOPHILIA |
3 |
0.0002 |
| 859 |
RHINORRHOEA |
11 |
0.0002 |
| 860 |
ASTHMA |
19 |
0.0002 |
| 861 |
BLOOD GLUCOSE DECREASED |
8 |
0.0002 |
| 862 |
BLOOD POTASSIUM DECREASED |
5 |
0.0002 |
| 863 |
OEDEMA |
9 |
0.0002 |
| 864 |
COMPLICATION OF DEVICE REMOVAL |
3 |
0.0002 |
| 865 |
DEHYDRATION |
22 |
0.0002 |
| 866 |
ILL-DEFINED DISORDER |
10 |
0.0002 |
| 867 |
UNDERDOSE |
12 |
0.0002 |
| 868 |
PRURITUS |
63 |
0.0002 |
| 869 |
OXYGEN SATURATION DECREASED |
9 |
0.0002 |
| 870 |
ABDOMINAL PAIN LOWER |
4 |
0.0002 |
| 871 |
PRODUCT COMPLAINT |
4 |
0.0002 |
| 872 |
SINUSITIS |
16 |
0.0002 |
| 873 |
ACCIDENTAL EXPOSURE TO PRODUCT |
16 |
0.0002 |
| 874 |
HERNIA |
3 |
0.0002 |
| 875 |
ANAPHYLACTIC SHOCK |
4 |
0.0002 |
| 876 |
HAEMATOMA |
4 |
0.0002 |
| 877 |
EXPOSURE VIA SKIN CONTACT |
4 |
0.0002 |
| 878 |
ARTHRALGIA |
64 |
0.0002 |
| 879 |
SWELLING FACE |
10 |
0.0002 |
| 880 |
CHILLS |
18 |
0.0002 |
| 881 |
INFLUENZA |
17 |
0.0002 |
| 882 |
PANCREATITIS |
8 |
0.0002 |
| 883 |
NEOPLASM MALIGNANT |
10 |
0.0001 |
| 884 |
GAIT INABILITY |
5 |
0.0001 |
| 885 |
SWELLING |
14 |
0.0001 |
| 886 |
TRANSIENT ISCHAEMIC ATTACK |
5 |
0.0001 |
| 887 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
5 |
0.0001 |
| 888 |
RENAL FAILURE |
19 |
0.0001 |
| 889 |
RASH MACULAR |
5 |
0.0001 |
| 890 |
BLISTER |
8 |
0.0001 |
| 891 |
MOBILITY DECREASED |
10 |
0.0001 |
| 892 |
INTERVERTEBRAL DISC PROTRUSION |
3 |
0.0001 |
| 893 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
4 |
0.0001 |
| 894 |
DRY SKIN |
18 |
0.0001 |
| 895 |
HEPATOTOXICITY |
3 |
0.0001 |
| 896 |
INFLUENZA LIKE ILLNESS |
11 |
0.0001 |
| 897 |
HEPATIC ENZYME INCREASED |
9 |
0.0001 |
| 898 |
GAIT DISTURBANCE |
25 |
0.0001 |
| 899 |
INJURY |
9 |
0.0001 |
| 900 |
DISEASE RECURRENCE |
6 |
0.0001 |
| 901 |
MULTIPLE SCLEROSIS |
6 |
0.0001 |
| 902 |
NASOPHARYNGITIS |
23 |
0.0001 |
| 903 |
HAEMORRHAGE |
13 |
0.0001 |
| 904 |
GASTROOESOPHAGEAL REFLUX DISEASE |
10 |
0.0001 |
| 905 |
DEVICE BREAKAGE |
5 |
0.0001 |
| 906 |
ALOPECIA |
24 |
0.0001 |
| 907 |
BRONCHITIS |
9 |
0.0001 |
| 908 |
STAPHYLOCOCCAL INFECTION |
4 |
0.0001 |
| 909 |
DIARRHOEA |
78 |
0.0001 |
| 910 |
MYOCARDIAL INFARCTION |
21 |
0.0001 |
| 911 |
SKIN DISORDER |
4 |
0.0001 |
| 912 |
CELLULITIS |
6 |
0.0001 |
| 913 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
3 |
0.0001 |
| 914 |
WHEEZING |
7 |
0.0001 |
| 915 |
PERIPHERAL SWELLING |
18 |
0.0001 |
| 916 |
ERYTHEMA |
24 |
0.0001 |
| 917 |
DYSPHAGIA |
11 |
0.0001 |
| 918 |
STOMATITIS |
7 |
0.0001 |
| 919 |
DEAFNESS |
3 |
0.0001 |
| 920 |
ASPARTATE AMINOTRANSFERASE INCREASED |
6 |
0.0001 |
| 921 |
THROMBOSIS |
9 |
0.0001 |
| 922 |
URINARY TRACT INFECTION |
19 |
0.0001 |
| 923 |
DRUG EFFECT INCOMPLETE |
4 |
0.0001 |
| 924 |
LOWER RESPIRATORY TRACT INFECTION |
5 |
0.0001 |
| 925 |
HYPERGLYCAEMIA |
4 |
0.0001 |
| 926 |
RESPIRATORY FAILURE |
8 |
0.0001 |
| 927 |
ARTHROPATHY |
6 |
0.0001 |
| 928 |
EYE SWELLING |
4 |
0.0001 |
| 929 |
COUGH |
30 |
0.0001 |
| 930 |
CARDIAC DISORDER |
10 |
0.0001 |
| 931 |
INTERNATIONAL NORMALISED RATIO INCREASED |
3 |
0.0001 |
| 932 |
HYPOGLYCAEMIA |
5 |
0.0001 |
| 933 |
PRODUCT STORAGE ERROR |
9 |
0.0001 |
| 934 |
NASAL CONGESTION |
6 |
0.0001 |
| 935 |
BURNING SENSATION |
7 |
0.0001 |
| 936 |
CARDIAC FAILURE |
8 |
0.0001 |
| 937 |
JOINT SWELLING |
12 |
0.0001 |
| 938 |
OEDEMA PERIPHERAL |
12 |
0.0001 |
| 939 |
HAEMOGLOBIN DECREASED |
10 |
0.0001 |
| 940 |
OSTEOPOROSIS |
4 |
0.0001 |
| 941 |
EPISTAXIS |
7 |
0.0001 |
| 942 |
FALL |
31 |
0.0001 |
| 943 |
HYPOACUSIS |
4 |
0.0001 |
| 944 |
BLOOD CREATININE INCREASED |
6 |
0.0001 |
| 945 |
INFUSION RELATED REACTION |
6 |
0.0001 |
| 946 |
ANGIOEDEMA |
4 |
0.0001 |
| 947 |
FUNGAL INFECTION |
3 |
0.0001 |
| 948 |
EYE PRURITUS |
3 |
0.0001 |
| 949 |
HAEMATURIA |
3 |
0.0001 |
| 950 |
SKIN IRRITATION |
4 |
0.0001 |
| 951 |
EYE IRRITATION |
5 |
0.0001 |
| 952 |
OCULAR HYPERAEMIA |
4 |
0.0001 |
| 953 |
PSORIASIS |
11 |
0.0001 |
| 954 |
DYSPNOEA EXERTIONAL |
3 |
0.0001 |
| 955 |
HOT FLUSH |
6 |
0.0001 |
| 956 |
INJECTION SITE SWELLING |
6 |
0.0001 |
| 957 |
PNEUMONIA |
25 |
0.0001 |
| 958 |
CONVULSION |
4 |
0.0001 |
| 959 |
DEVICE LEAKAGE |
3 |
0.0001 |
| 960 |
DEVICE DISLOCATION |
3 |
0.0001 |
| 961 |
BONE PAIN |
4 |
0.0001 |
| 962 |
NEUTROPENIA |
9 |
0.0001 |
| 963 |
NEUROPATHY PERIPHERAL |
6 |
0.0001 |
| 964 |
SEPSIS |
7 |
0.0001 |
| 965 |
INFECTION |
9 |
0.0001 |
| 966 |
RHEUMATOID ARTHRITIS |
7 |
0.0001 |
| 967 |
ATRIAL FIBRILLATION |
6 |
0.0001 |
| 968 |
INJECTION SITE PRURITUS |
4 |
0.0001 |
| 969 |
FLUID RETENTION |
3 |
0.0001 |
| 970 |
ACUTE KIDNEY INJURY |
9 |
0.0001 |
| 971 |
BLOOD GLUCOSE INCREASED |
11 |
0.0001 |
| 972 |
BREAST CANCER |
5 |
0.0001 |
| 973 |
HERPES ZOSTER |
3 |
0.0001 |
| 974 |
INJECTION SITE PAIN |
16 |
0.0001 |
| 975 |
CATARACT |
3 |
0.0001 |
| 976 |
INJECTION SITE BRUISING |
4 |
0.0001 |
| 977 |
INJECTION SITE ERYTHEMA |
6 |
0.0000 |
| 978 |
THROMBOCYTOPENIA |
5 |
0.0000 |
| 979 |
DISEASE PROGRESSION |
5 |
0.0000 |
| 980 |
DRUG DOSE OMISSION BY DEVICE |
3 |
0.0000 |
| 981 |
CARDIAC FAILURE CONGESTIVE |
3 |
0.0000 |
| 982 |
DEATH |
31 |
0.0000 |
| 983 |
GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0000 |
| 984 |
DEVICE ISSUE |
3 |
0.0000 |
| 985 |
ANAEMIA |
6 |
0.0000 |
| 986 |
DRUG DOSE OMISSION |
5 |
0.0000 |